683 Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

683 Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-82,500	Closed	-$21K	–	213
2020 Q3	$21K	Hold	82,500	–	–	﹤0.01%	141
2020 Q2	$37K	Hold	82,500	–	–	﹤0.01%	141
2020 Q1	$5K	Hold	82,500	–	–	﹤0.01%	147
2019 Q4	$15K	Hold	82,500	–	–	﹤0.01%	166
2019 Q3	$14K	Hold	82,500	–	–	﹤0.01%	151
2019 Q2	$18K	Hold	82,500	–	–	﹤0.01%	170
2019 Q1	$15K	Hold	82,500	–	–	﹤0.01%	165
2018 Q4	$32K	Hold	82,500	–	–	﹤0.01%	181
2018 Q3	$37K	Hold	82,500	–	–	﹤0.01%	161
2018 Q2	$31K	Hold	82,500	–	–	﹤0.01%	149
2018 Q1	$37K	Buy	+82,500	New	+$32.4K	﹤0.01%	142

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

683 Capital Management's NRXPW Position: Q4 2020 in Review

683 Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 82,500 shares — an estimated $21K sold.

683 Capital Management first reported a position in NRXPW in Q1 2018 and held it in 11 quarters. The position peaked at $37K in Q2 2020. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

683 Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
683 Capital Management sold 82,500 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $21K.
683 Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q1 2018 and held it in 11 quarters.
683 Capital Management's NRX Pharmaceuticals Warrant position peaked at $37K in Q2 2020.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on 683 Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.